Advanced search×

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.

Nat Struct Mol Biol 17(10):1247-54 (2010) PMID 20871615

Inherited mutations in human PALB2 are associated with a predisposition to breast and pancreatic cancers. PALB2's tumor-suppressing effect is thought to be based on its ability to facilitate BRCA2's function in homologous recombination. However, the biochemical properties of PALB2 are unknown. Here we show that human PALB2 binds DNA, preferentially D-loop structures, and directly interacts with the RAD51 recombinase to stimulate strand invasion, a vital step of homologous recombination. This stimulation occurs through reinforcing biochemical mechanisms, as PALB2 alleviates inhibition by RPA and stabilizes the RAD51 filament. Moreover, PALB2 can function synergistically with a BRCA2 chimera (termed piccolo, or piBRCA2) to further promote strand invasion. Finally, we show that PALB2-deficient cells are sensitive to PARP inhibitors. Our studies provide the first biochemical insights into PALB2's function with piBRCA2 as a mediator of homologous recombination in DNA double-strand break repair.

DOI: 10.1038/nsmb.1915
Version: za2963e q8za0 q8zba q8zca q8zd9 q8zed q8zf9 q8zgc

Similar articles you may find interesting…

  1. TRF2 promotes, remodels and protects telomeric Holliday junctions.

    EMBO J 28(6):641-51 (2009) PMID 19197240

    We show that TRF2 greatly increases the rate of Holliday junction (HJ) formation and blocks the cleavage by various types of HJ resolving activities, including the newly identified human GEN1 protein. By using potassium permanganate probing and differential scanning calorimetry, we reveal that the b...
  2. Optimal timing of delayed free lower abdominal flap breast reconstruction after postmastectomy radiation therapy.

    Plast Reconstr Surg 127(3):1100-6 (2011) PMID 21364413

    I and 107 (56.6 percent) in group II. The total flap loss rate was 2.6 percent, with all flap losses occurring in group I (p = 0.014). The reoperation rate was higher in group I (14.6 percent versus 4.7 percent; p = 0.022). In addition, group I patients trended toward a higher incidence of microvasc...
  3. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer.

    Int J Radiat Oncol Biol Phys 25(5):765-70 (1993) PMID 8478226

    Seventeen patients (6%) developed a local-regional failure at an interval of 4 to 87 months after radiotherapy. Moderate or severe complications related to radiotherapy and requiring treatment were uncommon. Symptomatic radiation pneumonitis occurred in four patients (1.3%), arm edema in 18 (5.8%),...